Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others may warrant more aggressive therapy, according to the findings of a new study led by an international group of researchers, including scientists from Harvard Medical School, and conducted across six countries in Asia, Africa, and South America.
from Medical Xpress - latest medical and health news stories https://ift.tt/oL7XudQ
